These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32345516)

  • 1. The protective and pathogenic roles of CXCL17 in human health and disease: Potential in respiratory medicine.
    Choreño-Parra JA; Thirunavukkarasu S; Zúñiga J; Khader SA
    Cytokine Growth Factor Rev; 2020 Jun; 53():53-62. PubMed ID: 32345516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive review of chemokine CXC17 (VCC1) in cancer, infection, and inflammation.
    Gowhari Shabgah A; Jadidi-Niaragh F; Ebrahimzadeh F; Mohammadi H; Askari E; Pahlavani N; Malekahmadi M; Ebrahimi Nik M; Gholizadeh Navashenaq J
    Cell Biol Int; 2022 Oct; 46(10):1557-1570. PubMed ID: 35811438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cryptic role of CXCL17/CXCR8 axis in the pathogenesis of cancers: a review of the latest evidence.
    Hashemi SF; Khorramdelazad H
    J Cell Commun Signal; 2023 Sep; 17(3):409-422. PubMed ID: 36352331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity.
    Burkhardt AM; Tai KP; Flores-Guiterrez JP; Vilches-Cisneros N; Kamdar K; Barbosa-Quintana O; Valle-Rios R; Hevezi PA; Zuñiga J; Selman M; Ouellette AJ; Zlotnik A
    J Immunol; 2012 Jun; 188(12):6399-406. PubMed ID: 22611239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cxcl17
    Hernández-Ruiz M; Othy S; Herrera C; Nguyen HT; Arrevillaga-Boni G; Catalan-Dibene J; Cahalan MD; Zlotnik A
    J Leukoc Biol; 2019 May; 105(5):1027-1039. PubMed ID: 30860634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal chemokine CXCL17: What is known and not known.
    Xiao S; Xie W; Zhou L
    Scand J Immunol; 2021 Feb; 93(2):e12965. PubMed ID: 32869346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL17-derived CD11b
    Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
    Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL17 is a major chemotactic factor for lung macrophages.
    Burkhardt AM; Maravillas-Montero JL; Carnevale CD; Vilches-Cisneros N; Flores JP; Hevezi PA; Zlotnik A
    J Immunol; 2014 Aug; 193(3):1468-74. PubMed ID: 24973458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What defines a chemokine? - The curious case of CXCL17.
    Giblin SP; Pease JE
    Cytokine; 2023 Aug; 168():156224. PubMed ID: 37210967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased epithelial and sputum miR-221-3p associates with airway eosinophilic inflammation and CXCL17 expression in asthma.
    Zhang K; Liang Y; Feng Y; Wu W; Zhang H; He J; Hu Q; Zhao J; Xu Y; Liu Z; Zhen G
    Am J Physiol Lung Cell Mol Physiol; 2018 Aug; 315(2):L253-L264. PubMed ID: 29644894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: GPR35/CXCR8 is the receptor of the mucosal chemokine CXCL17.
    Maravillas-Montero JL; Burkhardt AM; Hevezi PA; Carnevale CD; Smit MJ; Zlotnik A
    J Immunol; 2015 Jan; 194(1):29-33. PubMed ID: 25411203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL17-mediated downregulation of type I collagen via MMP1 and miR-29 in skin fibroblasts possibly contributes to the fibrosis in systemic sclerosis.
    Shimada S; Makino K; Jinnin M; Sawamura S; Kawano Y; Ide M; Kajihara I; Makino T; Fukushima S; Ihn H
    J Dermatol Sci; 2020 Dec; 100(3):183-191. PubMed ID: 33055012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL17 expression by tumor cells recruits CD11b+Gr1 high F4/80- cells and promotes tumor progression.
    Matsui A; Yokoo H; Negishi Y; Endo-Takahashi Y; Chun NA; Kadouchi I; Suzuki R; Maruyama K; Aramaki Y; Semba K; Kobayashi E; Takahashi M; Murakami T
    PLoS One; 2012; 7(8):e44080. PubMed ID: 22952881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells.
    Oka T; Sugaya M; Takahashi N; Takahashi T; Shibata S; Miyagaki T; Asano Y; Sato S
    J Immunol; 2017 May; 198(10):3897-3908. PubMed ID: 28389593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL17, an orphan chemokine, acts as a novel angiogenic and anti-inflammatory factor.
    Lee WY; Wang CJ; Lin TY; Hsiao CL; Luo CW
    Am J Physiol Endocrinol Metab; 2013 Jan; 304(1):E32-40. PubMed ID: 23115081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of lung adenocarcinoma spine metastasis induced by CXCL17.
    Liu W; Xie X; Wu J
    Cell Oncol (Dordr); 2020 Apr; 43(2):311-320. PubMed ID: 31832986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal guard: Human CXCL17 modulates protective response against mycotoxins and CXCL17-mimetic peptides development.
    Sun C; Shen H; Cai H; Zhao Z; Gan G; Feng S; Chu P; Zeng M; Deng J; Ming F; Ma M; Jia J; He R; Cao D; Chen Z; Li J; Zhang L
    Biochem Pharmacol; 2021 Jun; 188():114586. PubMed ID: 33932472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the Existence of a CXCL17 Receptor Distinct from GPR35.
    Binti Mohd Amir NAS; Mackenzie AE; Jenkins L; Boustani K; Hillier MC; Tsuchiya T; Milligan G; Pease JE
    J Immunol; 2018 Jul; 201(2):714-724. PubMed ID: 29875152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role and clinical significance of the CXCL17-CXCR8 (GPR35) axis in breast cancer.
    Guo YJ; Zhou YJ; Yang XL; Shao ZM; Ou ZL
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1159-1167. PubMed ID: 28943434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal Chemokines.
    Hernández-Ruiz M; Zlotnik A
    J Interferon Cytokine Res; 2017 Feb; 37(2):62-70. PubMed ID: 28207301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.